Research in focus: Antimicrobial resistance in cystic fibrosis
In October 2020 the Cystic Fibrosis Trust published a research in focus report on antimicrobial resistance (AMR) in cystic fibrosis. While AMR is a concern for us all, people living with CF are particularly vulnerable to it. The report highlights how CF researchers are leading the way in tackling AMR in CF, and how the ground-breaking approaches described in this report will be beneficial for people with CF in the future. Innovations made in tackling AMR in CF will also be applicable to solving AMR for all those with drug-resistant infections.
OUR UNDERWRITERS
Unrestricted financial support by:
 |
Antimicrobial Resistance Fighter Coalition |
 |
Bangalore Bioinnovation Centre |
 |
INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS |
 |
BD |
AMR NEWS
Your Biweekly Source for Global AMR Insights!
Stay informed with the essential newsletter that brings together all the latest One Health news on antimicrobial resistance. Delivered straight to your inbox every two weeks, AMR NEWS provides a curated selection of international insights, key publications, and the latest updates in the fight against AMR.
Don’t miss out on staying ahead in the global AMR movement—subscribe now!